Neutrophils mediate Th17 promotion in COVID-19 patients

. 2021 Jan ; 109 (1) : 73-76. [epub] 20201202

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid33289169

Grantová podpora
NU20-05-00320 Czech Ministry of Health AZV
GAUK 954218 Czech Ministry of Health AZV

From the beginning of 2020, an urgent need to understand the pathophysiology of SARS-CoV-2 disease (COVID-19), much of which is due to dysbalanced immune responses, resonates across the world. COVID-19-associated neutrophilia, increased neutrophil-to-lymphocyte ratio, aberrant neutrophil activation, and infiltration of neutrophils into lungs suggest that neutrophils are important players in the disease immunopathology. The main objective of this study was to assess the phenotypic and functional characteristics of neutrophils in COVID-19 patients, with particular focus on the interaction between neutrophils and T cells. We hypothesize that the altered functional characteristics of COVID-19 patient-derived neutrophils result in skewed Th1/Th17 adaptive immune response, thus contributing to disease pathology. The expansion of G-MDSC and immature forms of neutrophils was shown in the COVID-19 patients. In the COVID-19 neutrophil/T cell cocultures, neutrophils caused a strong polarity shift toward Th17, and, conversely, a reduction of IFNγ-producing Th1 cells. The Th17 promotion was NOS dependent. Neutrophils, the known modulators of adaptive immunity, skew the polarization of T cells toward the Th17 promotion and Th1 suppression in COVID-19 patients, contributing to the discoordinated orchestration of immune response against SARS-CoV-2. As IL-17 and other Th17-related cytokines have previously been shown to correlate with the disease severity, we suggest that targeting neutrophils and/or Th17 represents a potentially beneficial therapeutic strategy for severe COVID-19 patients.

Zobrazit více v PubMed

Cao  X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269-270. PubMed PMC

Xu  Z, Shi  L, Wang  Y, et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-422. PubMed PMC

Tan  M, Liu  Y, Zhou  R, et al.  Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology. 2020:261-268. PubMed PMC

Parackova  Z, Zentsova  I, Bloomfield  M, et al.  Disharmonic inflammatory signatures in COVID-19 : augmented neutrophils’ but impaired monocytes’ and dendritic cells’ responsiveness. Cells. 2020;9:1-19. PubMed PMC

Pacha  O, Sallman  MA, Evans  SE. COVID-19: a case for inhibiting IL-17?  Nat Rev Immunol. 2020;20:345-346. PubMed PMC

Huang  C, Wang  Y, Li  X, et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497-506. PubMed PMC

Mahallawi  WH, Khabour  OF, Zhang  Q, Makhdoum  HM, Suliman  BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8-13. PubMed PMC

Middleton  EA, He  X-Y, Denorme  F, et al.  Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020. PubMed PMC

Liu  J, Liu  Y, Xiang  P, et al.  Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. medRxiv. 2020. PubMed PMC

Fornasari  PM. COVID-19: neutrophils “unfriendly fire” imbalance proteolytic cascades triggering clinical worsening and viral sepsis. Potential Role Explanation for Convalescent Plasma as “Fire Hose”. 2020.

Pelletier  M, Maggi  L, Micheletti  A, et al.  Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 2010;115:335-343. PubMed

Wu  H, Zhen  Y, Ma  Z, et al.  Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med. 2016;8:331ra40. PubMed PMC

Obermajer  N, Wong  JL, Edwards  RP, et al.  Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med. 2013;210:1433-1445. PubMed PMC

Zhi  L, Ustyugova  IV, Chen  X, Zhang  Q, Wu  MX. Enhanced Th17 differentiation and aggravated arthritis in IEX-1–deficient mice by mitochondrial reactive oxygen species-mediated signaling. J Immunol. 2012;189:1639-1647. PubMed PMC

Zhang  D, Jin  W, Wu  R, et al.  High glucose intake exacerbates autoimmunity through reactive-oxygen-species-mediated TGF-β cytokine activation. Immunity. 2019;51:671-681. e5. PubMed PMC

Munder  M. Arginase: an emerging key player in the mammalian immune system: review. Br J Pharmacol. 2009;158:638-651. PubMed PMC

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens

. 2024 ; 14 () : 1384939. [epub] 20240528

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...